Table-II.
Response* | n (%) |
---|---|
All patients during treatment | |
Week 2 | 16/19 (84.2) |
Week 4 | 563/573 (98.2) |
Cirrhotic patients (triple therapy) | 19/23 (82.6) |
Relapse patients to interferon | 23/26 (88.4) |
Non responder to interferon (triple therapy) | 6/7 (85.7) |
With or without interferon | |
Double therapy | 497 (86.7) |
Triple Therapy | 76 (13.2) |
An HCV RNA level of 25 IU per milliliter (lower limit of quantification).